.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Baxter
Daiichi Sankyo
Harvard Business School
Express Scripts
McKinsey
McKesson
Mallinckrodt
Covington
Deloitte

Generated: June 29, 2017

DrugPatentWatch Database Preview

PRED MILD Drug Profile

« Back to Dashboard

Which patents cover Pred Mild, and what generic Pred Mild alternatives are available?

Pred Mild is a drug marketed by Allergan and is included in one NDA.

The generic ingredient in PRED MILD is prednisolone acetate. There are eighty-five drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the prednisolone acetate profile page.

Summary for Tradename: PRED MILD

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Bulk Api Vendors: see list45
Clinical Trials: see list3,392
Patent Applications: see list2,071
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PRED MILD at DailyMed

Pharmacology for Tradename: PRED MILD

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan
PRED MILD
prednisolone acetate
SUSPENSION/DROPS;OPHTHALMIC017100-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Harvard Business School
Cerilliant
Boehringer Ingelheim
Fuji
AstraZeneca
Deloitte
Cipla
Accenture
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot